Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells-Reference-Cited by-同舟云学术

Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells

Published:2021-10 Issue:10 Volume:1867 Page:166181
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Krishna Chandran Adwaid Manu,Coltrini Daniela,Belleri Mirella,Rezzola Sara,Gambicorti Elena,Romano Davide,Morescalchi Francesco,Calza Stefano,Semeraro Francesco,Presta Marco

Funder

Fondazione Umberto Veronesi

Università degli Studi di Brescia

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference49 articles.

1. Epiretinal membrane: optical coherence tomography-based diagnosis and classification;Stevenson;Clin. Ophthalmol.,2016

2. Macular diseases: epiretinal membrane;Inoue;Dev. Ophthalmol.,2014

3. Idiopathic epiretinal membrane;Bu;Retina,2014

4. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population;Ng;Ophthalmology,2011

5. Prevalence and risk factors for epiretinal membrane: the Singapore Epidemiology of Eye Disease study;Cheung;Br. J. Ophthalmol.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanics of the retina: Müller glia role on retinal extracellular matrix and modelling;Frontiers in Medicine;2024-09-04

2. Aqueous Humor Cytokines in Idiopathic Epiretinal Membrane: Correlation with Disease Severity;Diagnostics;2024-08-16

3. Pro-Fibrotic Role of Interleukin-4 in Influencing Idiopathic Epiretinal Membrane in Cataract Patients: Analysis From Clinical–Experimental Approaches;Translational Vision Science & Technology;2023-11-20

4. Tangential Retinal Displacement Increases After Macular Pucker Surgery: An Apparent Nonsense;Retina;2023-11-08

5. Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy;Stem Cell Research & Therapy;2023-09-21